<p>Centene（纽约证券交易所代码：CNC - 获取免费报告）在周五向投资者发布的报告中，巴克莱的股票研究分析师将其目标价格从 33.00 美元上调至 35.00 美元，Benzinga 报道。该券商目前对该股票的评级为 “持平”。巴克莱的目标价格意味着与公司当前价格相比，潜在上涨幅度为 2.49%。</p>
<ul>
<li>MarketBeat 周回顾 – 07/07 - 07/11</li>
</ul>
<p>其他几位股票研究分析师也最近对 CNC 发表了看法。桑福德·C·伯恩斯坦在 9 月 5 日的研究报告中将 Centene 的目标价格从 40.00 美元下调至 36.00 美元，并给予该公司 “跑赢大盘” 的评级。美国银行在 7 月 16 日的研究报告中将 Centene 的评级从 “中性” 下调至 “跑输大盘”，并将其目标价格从 52.00 美元下调至 30.00 美元。TD Cowen 在 7 月 21 日的研究报告中重申了 “持有” 评级，并将 Centene 的目标价格设定为 33.00 美元（从 73.00 美元下调）。Cantor Fitzgerald 在 8 月 26 日的报告中重申了 “中性” 评级，并对 Centene 的目标价格设定为 38.00 美元。最后，华尔街 Zen 在 7 月 12 日的报告中将 Centene 的评级从 “买入” 下调至 “持有”。三位分析师对该股票给予了 “买入” 评级，十三位分析师给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “持有”，共识目标价格为 38.33 美元。</p>
<p><strong>获取我们对 Centene 的最新分析</strong></p>
<h2>Centene 股票上涨 9.2%</h2>
<ul>
<li>为什么 Centene 股票下跌 40% — 现在是否值得买入</li>
</ul>
<p>CNC 在周五开盘价为 34.15 美元。Centene 的 52 周低点为 25.08 美元，52 周高点为 77.29 美元。该公司的债务与股本比率为 0.64，速动比率为 1.10，流动比率为 1.10。该公司的市值为 167.7 亿美元，市盈率为 8.45，市盈增长比率为 1.27，贝塔值为 0.44。该股票的 50 日移动平均线为 28.74 美元，200 日移动平均线为 48.08 美元。</p>
<p>Centene（纽约证券交易所代码：CNC - 获取免费报告）最近在 7 月 25 日发布了其财报。该公司报告本季度每股收益为（0.16 美元），低于分析师一致预期的 0.23 美元，差距为（0.39 美元）。该公司本季度的收入为 487.4 亿美元，而分析师预期为 447.1 亿美元。Centene 的股本回报率为 9.57%，净利润率为 1.15%。该公司的季度收入同比增长 22.4%。在去年同期，该公司每股收益为 2.42 美元。Centene 已将其 2025 财年的指导目标设定为 1.750-1.750 每股收益。平均而言，股票分析师预计 Centene 在当前年度的每股收益为 6.86 美元。</p>
<h2>Centene 的内部买卖</h2>
<ul>
<li>当前值得关注的顶级分析师评级的医疗保健股票</li>
</ul>
<p>在相关消息中，董事 Theodore R. Samuels II 在 7 月 28 日的交易中购买了 9,000 股该股票。该股票的平均购买成本为每股 27.62 美元，总价值为 248,580.00 美元。交易完成后，该董事直接持有该公司 32,000 股股票，价值约为 883,840 美元。这笔交易代表了他们持股比例的 39.13% 的增加。该交易已在证券交易委员会的备案中披露，相关信息可在 SEC 网站上找到。此外，首席执行官 Sarah London 在 8 月 8 日的交易中购买了 19,230 股该股票。该股票的平均购买成本为每股 25.50 美元，总价值为 490,365.00 美元。交易完成后，首席执行官持有该公司 845,275 股股票，价值为 21,554,512.50 美元。这笔交易使他们的持股比例增加了 2.33%。该购买的披露信息可以在此找到。公司内部人士持有该股票的 0.36%。</p>
<h2>机构资金流入和流出</h2>
<p>对冲基金最近对该公司的持仓进行了调整。Pinney &amp; Scofield Inc.在第四季度购买了 Centene 的新头寸，价值约为 25,000 美元。Ameriflex Group Inc.在第四季度购买了 Centene 的新头寸，价值约为 26,000 美元。Quarry LP 在第一季度购买了 Centene 的新头寸，价值约为 26,000 美元。Studio Investment Management LLC 在第四季度收购了 Centene 的新头寸，价值约为 32,000 美元。最后，Golden State Wealth Management LLC 在第一季度将其在 Centene 的持股增加了 203.1%。Golden State Wealth Management LLC 现在拥有 579 股该公司的股票，价值为 35,000 美元，此前在该期间内又购买了 388 股。93.63% 的股票由机构投资者持有。</p>
<h2>Centene 公司简介</h2>
<p>（获取免费报告）</p>
<p>Centene Corporation 作为一家医疗保健企业，向美国的低收入和无保险家庭、商业组织和军人家庭提供项目和服务。该公司通过医疗补助、医疗保险、商业和其他部门运营。医疗补助部门提供健康计划覆盖，包括医疗补助扩展、老年、盲人、残疾人、儿童健康保险计划、寄养护理、医疗保险 - 医疗补助计划、长期服务和支持。</p>
<h2>另请参阅</h2>
<ul>
<li>我们更看好的五只股票</li>
<li>最具波动性的股票，投资者需要知道的事项</li>
<li>宇宙降低前景：巴菲特的大赌注是否值得恐慌？</li>
<li>S&amp;P/TSX 指数是什么？</li>
<li>现在可能是购买德州仪器的时机</li>
<li>如何选择顶级评级股票</li>
<li>高飞股票接近阻力位：3 只股票值得关注以寻找回调</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOQw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 Centene 吗？</h2>
<p>在考虑 Centene 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Centene 并不在名单上。</p>
<p>虽然 Centene 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

康西哥

<p>巴克莱将 Centene（纽约证券交易所代码：CNC）的目标价从 33.00 美元上调至 35.00 美元，维持 “持平” 评级。这个新目标暗示与当前价格相比有 2.49% 的潜在上涨空间。其他分析师的看法各不相同，有些分析师大幅下调了他们的目标价。Centene 的股票开盘价为 34.15 美元，52 周价格区间为 25.08 美元至 77.29 美元。该公司报告的收入同比增长 22.4%，但在上个季度未能达到盈利预期</p>

<p>Centene (NYSE:CNC - Get Free Report) had its price objective raised by equities research analysts at Barclays from $33.00 to $35.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has an &#34;equal weight&#34; rating on the stock. Barclays's target price would indicate a potential upside of 2.49% from the company's current price.</p>
<div class="lb-trans"><p>Centene（纽约证券交易所代码：CNC - 获取免费报告）在周五向投资者发布的报告中，巴克莱的股票研究分析师将其目标价格从 33.00 美元上调至 35.00 美元，Benzinga 报道。该券商目前对该股票的评级为 “持平”。巴克莱的目标价格意味着与公司当前价格相比，潜在上涨幅度为 2.49%。</p>
</div><ul>
<li>MarketBeat Week in Review – 07/07 - 07/11</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 07/07 - 07/11</li>
</ul>
</div><p>Several other equities research analysts have also recently weighed in on CNC. Sanford C. Bernstein cut their price objective on shares of Centene from $40.00 to $36.00 and set an &#34;outperform&#34; rating for the company in a research report on Friday, September 5th. Bank of America cut shares of Centene from a &#34;neutral&#34; rating to an &#34;underperform&#34; rating and decreased their price objective for the company from $52.00 to $30.00 in a research note on Wednesday, July 16th. TD Cowen restated a &#34;hold&#34; rating and set a $33.00 target price (down from $73.00) on shares of Centene in a research note on Monday, July 21st. Cantor Fitzgerald reaffirmed a &#34;neutral&#34; rating and issued a $38.00 target price on shares of Centene in a report on Tuesday, August 26th. Finally, Wall Street Zen cut shares of Centene from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, July 12th. Three analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of &#34;Hold&#34; and a consensus price target of $38.33.</p>
<div class="lb-trans"><p>其他几位股票研究分析师也最近对 CNC 发表了看法。桑福德·C·伯恩斯坦在 9 月 5 日的研究报告中将 Centene 的目标价格从 40.00 美元下调至 36.00 美元，并给予该公司 “跑赢大盘” 的评级。美国银行在 7 月 16 日的研究报告中将 Centene 的评级从 “中性” 下调至 “跑输大盘”，并将其目标价格从 52.00 美元下调至 30.00 美元。TD Cowen 在 7 月 21 日的研究报告中重申了 “持有” 评级，并将 Centene 的目标价格设定为 33.00 美元（从 73.00 美元下调）。Cantor Fitzgerald 在 8 月 26 日的报告中重申了 “中性” 评级，并对 Centene 的目标价格设定为 38.00 美元。最后，华尔街 Zen 在 7 月 12 日的报告中将 Centene 的评级从 “买入” 下调至 “持有”。三位分析师对该股票给予了 “买入” 评级，十三位分析师给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “持有”，共识目标价格为 38.33 美元。</p>
</div><p><strong>Get Our Latest Analysis on Centene</strong></p>
<div class="lb-trans"><p><strong>获取我们对 Centene 的最新分析</strong></p>
</div><h2>Centene Stock Up 9.2%</h2>
<div class="lb-trans"><h2>Centene 股票上涨 9.2%</h2>
</div><ul>
<li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 Centene 股票下跌 40% — 现在是否值得买入</li>
</ul>
</div><p>CNC opened at $34.15 on Friday. Centene has a fifty-two week low of $25.08 and a fifty-two week high of $77.29. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The company has a market capitalization of $16.77 billion, a P/E ratio of 8.45, a P/E/G ratio of 1.27 and a beta of 0.44. The stock has a fifty day moving average of $28.74 and a 200-day moving average of $48.08.</p>
<div class="lb-trans"><p>CNC 在周五开盘价为 34.15 美元。Centene 的 52 周低点为 25.08 美元，52 周高点为 77.29 美元。该公司的债务与股本比率为 0.64，速动比率为 1.10，流动比率为 1.10。该公司的市值为 167.7 亿美元，市盈率为 8.45，市盈增长比率为 1.27，贝塔值为 0.44。该股票的 50 日移动平均线为 28.74 美元，200 日移动平均线为 48.08 美元。</p>
</div><p>Centene (NYSE:CNC - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by ($0.39). The firm had revenue of $48.74 billion for the quarter, compared to analyst estimates of $44.71 billion. Centene had a return on equity of 9.57% and a net margin of 1.15%.The firm's quarterly revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the business posted $2.42 EPS. Centene has set its FY 2025 guidance at 1.750-1.750 EPS. On average, equities analysts expect that Centene will post 6.86 EPS for the current year.</p>
<div class="lb-trans"><p>Centene（纽约证券交易所代码：CNC - 获取免费报告）最近在 7 月 25 日发布了其财报。该公司报告本季度每股收益为（0.16 美元），低于分析师一致预期的 0.23 美元，差距为（0.39 美元）。该公司本季度的收入为 487.4 亿美元，而分析师预期为 447.1 亿美元。Centene 的股本回报率为 9.57%，净利润率为 1.15%。该公司的季度收入同比增长 22.4%。在去年同期，该公司每股收益为 2.42 美元。Centene 已将其 2025 财年的指导目标设定为 1.750-1.750 每股收益。平均而言，股票分析师预计 Centene 在当前年度的每股收益为 6.86 美元。</p>
</div><h2>Insider Buying and Selling at Centene</h2>
<div class="lb-trans"><h2>Centene 的内部买卖</h2>
</div><ul>
<li>Top Analyst-Rated Healthcare Stocks to Watch Now</li>
</ul>
<div class="lb-trans"><ul>
<li>当前值得关注的顶级分析师评级的医疗保健股票</li>
</ul>
</div><p>In related news, Director Theodore R. Samuels II bought 9,000 shares of the stock in a transaction that occurred on Monday, July 28th. The stock was acquired at an average cost of $27.62 per share, with a total value of $248,580.00. Following the transaction, the director directly owned 32,000 shares in the company, valued at approximately $883,840. This trade represents a 39.13% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, CEO Sarah London bought 19,230 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were bought at an average cost of $25.50 per share, with a total value of $490,365.00. Following the completion of the transaction, the chief executive officer owned 845,275 shares in the company, valued at $21,554,512.50. The trade was a 2.33% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.36% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，董事 Theodore R. Samuels II 在 7 月 28 日的交易中购买了 9,000 股该股票。该股票的平均购买成本为每股 27.62 美元，总价值为 248,580.00 美元。交易完成后，该董事直接持有该公司 32,000 股股票，价值约为 883,840 美元。这笔交易代表了他们持股比例的 39.13% 的增加。该交易已在证券交易委员会的备案中披露，相关信息可在 SEC 网站上找到。此外，首席执行官 Sarah London 在 8 月 8 日的交易中购买了 19,230 股该股票。该股票的平均购买成本为每股 25.50 美元，总价值为 490,365.00 美元。交易完成后，首席执行官持有该公司 845,275 股股票，价值为 21,554,512.50 美元。这笔交易使他们的持股比例增加了 2.33%。该购买的披露信息可以在此找到。公司内部人士持有该股票的 0.36%。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Hedge funds have recently made changes to their positions in the business. Pinney &amp; Scofield Inc. bought a new position in shares of Centene in the 4th quarter worth about $25,000. Ameriflex Group Inc. bought a new position in shares of Centene in the 4th quarter worth about $26,000. Quarry LP bought a new position in shares of Centene in the 1st quarter worth about $26,000. Studio Investment Management LLC acquired a new position in Centene during the 4th quarter worth approximately $32,000. Finally, Golden State Wealth Management LLC raised its stake in Centene by 203.1% during the 1st quarter. Golden State Wealth Management LLC now owns 579 shares of the company's stock worth $35,000 after buying an additional 388 shares during the period. 93.63% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>对冲基金最近对该公司的持仓进行了调整。Pinney &amp; Scofield Inc.在第四季度购买了 Centene 的新头寸，价值约为 25,000 美元。Ameriflex Group Inc.在第四季度购买了 Centene 的新头寸，价值约为 26,000 美元。Quarry LP 在第一季度购买了 Centene 的新头寸，价值约为 26,000 美元。Studio Investment Management LLC 在第四季度收购了 Centene 的新头寸，价值约为 32,000 美元。最后，Golden State Wealth Management LLC 在第一季度将其在 Centene 的持股增加了 203.1%。Golden State Wealth Management LLC 现在拥有 579 股该公司的股票，价值为 35,000 美元，此前在该期间内又购买了 388 股。93.63% 的股票由机构投资者持有。</p>
</div><h2>Centene Company Profile</h2>
<div class="lb-trans"><h2>Centene 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.</p>
<div class="lb-trans"><p>Centene Corporation 作为一家医疗保健企业，向美国的低收入和无保险家庭、商业组织和军人家庭提供项目和服务。该公司通过医疗补助、医疗保险、商业和其他部门运营。医疗补助部门提供健康计划覆盖，包括医疗补助扩展、老年、盲人、残疾人、儿童健康保险计划、寄养护理、医疗保险 - 医疗补助计划、长期服务和支持。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than Centene</li>
<li>Most Volatile Stocks, What Investors Need to Know</li>
<li>Constellation Lowers Outlook: Time to Panic on Buffett's Big Bet?</li>
<li>What is the S&amp;P/TSX Index?</li>
<li>It May Be Time to Buy the Dip in Texas Instruments</li>
<li>How to Choose Top Rated Stocks</li>
<li>High-Flyers Near Resistance: 3 Stocks to Watch for a Dip</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票</li>
<li>最具波动性的股票，投资者需要知道的事项</li>
<li>宇宙降低前景：巴菲特的大赌注是否值得恐慌？</li>
<li>S&amp;P/TSX 指数是什么？</li>
<li>现在可能是购买德州仪器的时机</li>
<li>如何选择顶级评级股票</li>
<li>高飞股票接近阻力位：3 只股票值得关注以寻找回调</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=CNC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Centene Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Centene 吗？</h2>
</div><p>Before you consider Centene, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Centene 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Centene 并不在名单上。</p>
</div><p>While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Centene 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

巴克莱预测康西哥（NYSE:CNC）股票价格将大幅上涨